PeptideDB

BW 348U87 127142-14-7

BW 348U87 127142-14-7

CAS No.: 127142-14-7

BW 348U87 is a ribonucleotide reductase inhibitor that acts synergistically with Acyclovir and enhances the antiviral ac
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

BW 348U87 is a ribonucleotide reductase inhibitor that acts synergistically with Acyclovir and enhances the antiviral activity of Acyclovir against herpes simplex virus (HSV) in an athymic nude mouse model.

Physicochemical Properties


Molecular Formula C15H15CLN6S2
Molecular Weight 378.90
CAS # 127142-14-7
Appearance Typically exists as solids at room temperature
SMILES

S=C(N/N=C(/C1=CC=CC=N1)\C)NNC(NC1=CC=CC=C1Cl)=S

Synonyms

348U87
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: (1). This product requires protection from light (avoid light exposure) during transportation and storage.(2). Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Spector T, et al., Inactivators of herpes simplex virus ribonucleotide reductase: hematological profiles and in vivo potentiation of the antiviral activity of acyclovir. Antimicrob Agents Chemother. 1992 May;36(5):934-7.


Solubility Data


Solubility (In Vitro) DMSO : ~25 mg/mL (~65.98 mM; with ultrasonication)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 1.25 mg/mL (3.30 mM) (saturation unknown) in 10% DMSO +40% PEG300 +5% Tween-80 +45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution。
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 1.25 mg/mL (3.30 mM) (saturation unknown) in 10% DMSO +90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution。
For example, if 1 mL of working solution is to be prepared, You can add 100 μL of the 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD in saline and mix well.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 1.25 mg/mL (3.30 mM) (saturation unknown) in 10% DMSO +90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution。
For example, if 1 mL of working solution is to be prepared, You can add 100 μL of the 12.5 mg/mL clear DMSO stock solution to 900 μL corn oil and mix well.

" (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6392 mL 13.1961 mL 26.3922 mL
5 mM 0.5278 mL 2.6392 mL 5.2784 mL
10 mM 0.2639 mL 1.3196 mL 2.6392 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.